Recombinant human endostatin
[2012]-10-24
Phase 2 small_molecule completed
Quick answer
Recombinant human endostatin for Stage III Non-small-Cell Lung Cancer is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Stage III Non-small-Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed